C07K 16/126
Legionella
Official title: Legionella (G)
C07K16/126 (Legionella) appears on 9 US grants and 6 published applications in this corpus.
Search patents in C07K- Granted patents
- 9
- Published applications
- 6
- Assignees
- 10
- Inventors
- 26
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Lipopolysaccharide-targeted peptide mimic vaccine against Q fever19 Mar 2019US 10,233,233 B2The Curators of the University of Missouri
- Method for detection of Legionella bacteria employing purified antigen-specific antibodies5 Jun 2018US 9,989,529 B2Alere Scarborough, Inc.
- Lipopolysaccharide-targeted peptide mimic vaccine against Q fever23 Aug 2016US 9,422,545 B2The Curators of the University of Missouri
- ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto15 Sep 2015US 9,134,303 B1Alere Scarborough, Inc.
- Antibodies17 Sep 2026US 2026/0273037 A1Hydrosense Ltd
- Method and kit for detecting presence and/or amount of bacteria in food/drink sample, environmental sample, or biological sample29 Feb 2024US 2024/0069021 A1Asahi Kasei Kabushiki Kaisha
- Engineered binding proteins for recognition of bacteria9 Nov 2023US 2023/0358742 A1Massachusetts Institute of Technology
- Lipopolysaccharide-Targeted Peptide Mimic Vaccine Against Q Fever20 Oct 2016US 2016/0304587 A1The Curators of the University of Missouri
- Method for Detection of Legionella Bacteria Employing Purified Antigen-Specific Antibodies18 Feb 2016US 2016/0047807 A1Alere Scarborough, Inc.
Most cited
By later US patents
- Monoclonal antibodies to legionella, a process for their preparation and their use in the determination of legionella pneumophila9US 4,780,407 ACentre National De La Recherche Scientifique · 1988
- Method and composition for the detection and diagnosis of Legionella pneumophila4US 4,851,333 AGenetic Systems Corporation · 1989
- Monoclonal antibodies to legionella4US 4,931,547 AThe University of Tennesse Research Corporation · 1990
- Immunodiagnostic reagent specific for legionella3US 5,248,594 AThe United States of America as represented by the Department of Health and Human Services · 1993
- ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto1US 9,134,303 B1Alere Scarborough, Inc. · 2015